Breathe Technologies, Inc., a manufacturer of innovative technology solutions for people with respiratory conditions, including chronic obstructive pulmonary disease (COPD), announced today that it has received FDA clearance for use of the Breathe Technologies BT-V2S ventilator in the home setting. The one-pound portable device provides ventilation assistance to aid select adult patients who suffer from respiratory insufficiency.

“This marks an important milestone not only for Breathe, but for the future of COPD disease management and patient quality of life,” remarked Larry Mastrovich, President and CEO. “Patients with advanced COPD frequently suffer a loss of mobility, which may accelerate their respiratory disease progression and lead to decreased functional abilities.  We are delighted to be able to offer this technology for patients to use in their homes because it has the potential to significantly improve their ability to perform activities of daily living.” Read the rest of this entry

Elkhart General Hospital Home Medical Equipment, 225 E. Jackson Blvd., is offering a free CPAP/BiPAP Clinic from 9 a.m. to 4 p.m. Tuesday.

Take the opportunity to ensure your sleep apnea equipment is working efficiently and effectively with one-on-one service from respiratory specialists.

Appointments take about 20 minutes and include pressure checks, mask and supply evaluations, filter changes and new equipment displays.

To make an appointment, call 574-523-3100 or toll-free at 888-517-3100. Walk-ins are welcome on a space-available basis.

UVa Health System, Department of Medicine, Pulmonary Division seeks healthy men, women, children and adolescents ages 5 to 65, with snoring and possible sleep-related obstructive breathing disorders for a research study.

The purpose of the study is to determine if an experimental device for sleep monitoring can accurately tell if you are awake or asleep and how well you are sleeping. The experimental device will be compared to a sleep study done using standard sleep monitoring equipment.
The study involves 1 outpatient consent and screening visit that will last about 1 hour, and 1 overnight stay at UVa Health Systems GCRC of about 16 hours for sleep monitoring.

§ Study-related screening visit and overnight sleep test (standard test to detect the presence of sleep apnea) provided free of charge.
§ Compensation for study completion is $ 125.00
Read the rest of this entry

SleepApneaDisorder/ BOSTON, Mass./  Sleep HealthCenters has entered into an agreement with Roadside Medical Clinic + Lab to provide sleep medicine services as part of Roadside Medical’s industry-leading Driver Wellness programs.

Designed to enhance roadway safety by improving the health of commercial drivers, Roadside Medical Clinic + Lab provides cost-effective and professional medical services including DOT compliant physicals, drug testing, Driver Wellness Programs, and now sleep services in the most convenient locations for professional drivers—both on the highway and in company terminals. Sleep HealthCenters will support Roadside’s sleep wellness program by providing education, professional diagnosis and treatment support, all incorporated into Roadside’s overall Driver Wellness program. Read the rest of this entry

SleepApneaDisorder/ [ Press Release ] / Tuesday, October 26, 2010/:  Millions of people worldwide, who suffer from the debilitating effects of sleep apnea, will benefit from a new device to treat the health condition, thanks to an innovative technology partnership between ResMed and STMicroelectronics.

Sleep apnea, a common but little-known disorder, affects 1 in 5 adults1.

It stems from closure of the airway during sleep which causes breathing to stop, sometimes for more than a minute; often leaving the person affected gasping for air. In severe cases, this can happen hundreds of times each night leading to serious health risks, including increased heart rate, higher blood pressure and potentially, heart attack and cardiovascular disease. Read the rest of this entry

According to a new report by iData Research , the leading global authority in medical device and pharmaceutical market research, the U.S. patient monitoring market is expected to reach almost $4 billion by 2017. Multi-parameter vital-sign devices represented the majority of the patient monitoring market in 2010, with the home telehealth segment growing over 17% in 2010 and the hospital wireless telemetry monitoring segment growing at high double-digit rates. The second largest segment of this market was pulse oximetry, which is expected to exceed $934 million by 2017. Read the rest of this entry

As Americans get heavier and heavier, the incidence of obstructive sleep apnea increases, and results from two clinical studies presented at ANESTHESIOLOGY 2010 reinforce the need for physicians to screen for the disorder prior to surgery in order to appropriately manage the patient in the operating room.

“If patients with unidentified obstructive sleep apnea undergo surgery, they may have an increased chance of experiencing complications during and after surgery,” said Frances Chung, F.R.C.P.C., investigator on both studies and Professor, Department of Anesthesia, University Health Network, University of Toronto. “A growing amount of evidence suggests that obstructive sleep apnea is associated with heart and lung disease, diabetes mellitus and a higher rate of early death.” Read the rest of this entry

San Diego — As health officials continue to monitor the physical and monetary toll sleep disorders exact in the U.S., treating various conditions brought on by sleep problems has transformed snoozing into a sound business for a San Diego-based medical device manufacturer.

And the market of potential customers has yet to be fully realized, said officials at ResMed, a sleep apnea device maker with about 325 local employees.

In addition to announcing record revenues recently, ResMed is teaming up with a major competitor to educate the medical community in a $1 million campaign to help reach millions of undiagnosed Americans with sleeping disorders, especially sleep apnea. Read the rest of this entry

SleepApneaDisorder/[Press Release]/ FRANKLIN, Mass./–In accordance with the new guidelines issued by the American Society of Anesthesiologists to improve the perioperative care and reduce the risk of adverse outcomes in patients with Obstructive Sleep Apnea (OSA), Itamar-Medical’s WatchPAT device for home sleep testing is already being used to effectively deliver fast, patient-satisfying results for pre-operative sleep testing.

“Patients with undiagnosed sleep apnea have a higher complication rate, longer recovery, and poorer pain control,” said Dr. Marvin Tark, head of the Pain Management Section and former Chairman of Anesthesia at Wellstar Kennestone Hospital, Marietta, Georgia. “WatchPAT provides the information we need to monitor and manage the patient better in both the surgical and the post-operative period, offering the best possible high-quality medical care. Read the rest of this entry

SleepApneaDisorder/[Press Release]/ SAN DIEGO/ –ResMed , a leading developer, manufacturer, and distributor of sleep and respiratory medical equipment today announced the results of a clinical study confirming that patients’ compliance with sleep therapy increases when using ResMed’s new CPAP device. 

The clinical study of 50 patients suffering from sleep apnea showed an improvement of 30 minutes in average daily usage, from a mean of 6 hours 35 minutes on the patient’s usual CPAP device, to 7 hours 5 minutes, when using the new S9 Series. Read the rest of this entry

Elkhart General Hospital Home Medical Equipment, 225 E. Jackson Blvd., is offering a free CPAP/BiPAP Clinic from 8 a.m. to 4 p.m. Sept. 21.

Take the opportunity to ensure your sleep apnea equipment is working efficiently and effectively with one-on-one service from respiratory specialists.

To make an appointment, call 574-523-3100 or toll-free at 888-517-3100. Walk-ins are welcome on a space available basis.

SleepApneaDisorder/[Press Release]/- BOCA RATON, Fla., Sept. 15 / — Watermark Medical, Inc., a privately-held, medical products and services company servicing the sleep-disordered breathing market, has expanded the market reach of its Web-enabled in-home sleep apnea testing device through strategic alliances with three leading sleep solution providers in the U.S. and Canada.

The new partners are SleepQuest, a national provider of comprehensive sleep apnea services; Sleep Optima, which provides sleep apnea services through a growing network of dentists; and The Snore Shop, which offers sleep apnea services. Based on Watermark Medical’s expertise and credibility in the in-home testing market, these companies chose to use the Watermark ARES™ in three distinct types of practice settings, demonstrating the versatility of the Watermark device. Read the rest of this entry

SleepApneaDisorder/[Press Release]/-The Ultimate Stop Snoring Solution is a new anti-snoring device that enables a quiet night of refreshing sleep. Each set is customized based on jaw position, breathing habits, teeth grinding habits and TMJ issues, ensuring a comfortable night’s sleep. These unique dentist-invented adjustable devices move the jaw forward in small increments to stop snoring and are now available without a prescription at http://www.UltimateStopSnoringSolution.com Read the rest of this entry

The Cuyahoga County New Product Development and Entrepreneurship Loan Fund awarded Cleveland Medical Devices Inc. $60,000 to step up commercialization of the company’s SleepView device for sleep apnea screening at home.

CleveMed has a lineup of wireless diagnostic sleep systems, including SleepView, which is the smallest and lightest home sleep monitor with an American Academy of Sleep Medicine-recommended Type 3 channel set.

“This is all about, how do we start to commercialize this more?” said CleveMed chairman Bob Schmidt. “We want to expand from the hundreds of places [where the device is used] now to thousands of places.”

CleveMed develops innovative biomedical signal processing and instrumentation devices for sleep and movement disorders, like Parkinson’s.

[Press Release]-/-Servoflo Corporation of Lexington, Massachusetts is pleased to announce the MS5701 low pressure sensor with an I2C or SPI digital interface. Available in either differential or gauge models, the MS5701 can measure as low as ±2.5″ H2O up to ±10″ H2O in a differential version. The gauge model comes in ranges from +2″ H2O to +20″ H2O.

Using the latest in MEMS technology, the MS5701 has a low supply voltage of 1.8 to 3.6V with a 1 mA power consumption. Furthermore, the MS5701 pressure sensor has a high resolution of 0.0004″ of water (0.001 mbar) and a fast conversion of 0.54 milliseconds. A 24-bit pressure and temperature output allows for integration to any microcontroller. The I2C or SPI interface communicates up to 20 MHz. Read the rest of this entry